Eastover Investment Advisors LLC Bristol Myers Squibb CO Transaction History

Eastover Investment Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $136,794 - $152,956	2,363 Added 3.33%	73,415 $4.26 Million
Q2 2023 Jul 25, 2023	BUY	$63.71 - $70.74 $19,813 - $22,000	311 Added 0.44%	71,052 $4.54 Million
Q1 2023 Apr 14, 2023	BUY	$65.71 - $74.53 $89,037 - $100,988	1,355 Added 1.95%	70,741 $4.9 Million
Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $52,729 - $62,439	770 Added 1.12%	69,386 $0
Q3 2022 Oct 11, 2022	BUY	$0.13 - $76.84 $137 - $81,296	1,058 Added 1.57%	68,616 $4.78 Million
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $407,398 - $448,687	-5,610 Reduced 7.67%	67,558 $5.2 Million
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $517,292 - $620,280	8,414 Added 12.99%	73,168 $5.34 Million
Q4 2021 Jan 12, 2022	BUY	$53.63 - $62.52 $105,919 - $123,477	1,975 Added 3.15%	64,754 $4.04 Million
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $14,259 - $16,703	241 Added 0.39%	62,779 $3.72 Million
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $224,052 - $243,992	3,619 Added 6.14%	62,538 $4.18 Million
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $117,730 - $132,412	-1,984 Reduced 3.26%	58,919 $3.72 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $4,215 - $4,776	73 Added 0.12%	60,903 $3.78 Million
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $75,865 - $84,068	1,321 Added 2.22%	60,830 $3.67 Million
Q2 2020 Jul 21, 2020	BUY	$54.82 - $64.09 $109,091 - $127,539	1,990 Added 3.46%	59,509 $3.5 Million
Q1 2020 Apr 20, 2020	BUY	$46.4 - $67.43 $2.67 Million - $3.88 Million	57,519 New	57,519 $3.21 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Eastover Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eastover Investment Advisors LLC with notifications on news.